Differential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension

Psychiatric Services

Volumn 58, Issue 2, 2007, Pages 207-212

  Piette, John D ^a,b   Heisler, Michele ^a,b   Ganoczy, Dara ^a   McCarthy, John F ^a,c   Valenstein, Marcia ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; BEHAVIOR; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DRUG USE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT PARTICIPATION; SCHIZOPHRENIA; SELF CARE;

EID: 33847342430     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.2007.58.2.207     Document Type: Article

References (36)

1. Robinson D, Woerner MG, Alvir JM, et al: Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry 56:241-247, 1999
2. Rubin RR: Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. American Journal of Medicine 118(suppl):27S-34S, 2005
3. Stephenson J: Noncompliance may cause half of antihypertensive drug "failures." JAMA 282:313-314, 1999
4. Viguera AC, Baldessarini RJ, Hegarty JD, et al: Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Archives of General Psychiatry 54:49-55, 1997
5. Valenstein M, Copeland LA, Blow FC, et al: Pharmacy data identifies poorly adherent patients at increased risk for admission. Medical Care 40:630-639, 2002
6. Gilmer TP, Dolder CR, Lacro JP et al: Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry 161:692-699, 2004
7. Weiden PJ, Kozma C, Grogg A, et al: Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatric Services 55:886-891, 2004
8. Osterberg L, Blaschke T: Adherence to medication. New England Journal of Medicine 353:487-497, 2005
9. Valenstein M, Blow FC, Copeland LA, et al: Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophrenia Bulletin 30:255-264, 2004
10. Cramer JA, Rosenheck R: Enhancing medication compliance for people with serious mental illnesses. Journal of Nervous and Mental Disease 187:53-55, 1999
11. Fenton WS, Blyler CR, Heinssen RK: Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophrenia Bulletin 23:637-651, 1997
12. McCombs JS, Nichol MB, Stimmel GL, et al: Use patterns for antipsychotic medications in Medicaid patients with schizophrenia. Journal of Clinical Psychiatry 60:5-11, 1999
13. Adherence to long term therapies: evidence for action. Geneva, World Health Organization, 2003
14. DiMatteo MR: Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Medical Care 42:200-209, 2004
15. Lacro JP, Dunn LB, Dolder CR, et al: Prevalence of and risk factors for medication non-adherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry 63:892-909, 2002
16. Horne R, Weinman J: Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic illness. Journal of Psychosomatic Research 47:555-567, 1999
17. Goldman D, Joyce GF, Escarce JJ, et al: Pharmacy benefits and the use of drugs by the chronically ill. JAMA 291:2344-2350, 2004
18. Martin BC, McMillan JA: The impact of implementing a more restrictive prescription limit on Medicaid recipients: effects on cost, therapy, and out-of-pocket expenditures. Medical Care 34:686-701, 1996
19. Piette JD, Heisler M, Horne R, et al: A conceptually-based approach to understanding chronically-ill patients' responses to medication cost pressures. Social Science and Medicine 62:846-857, 2006
20. Redelmeier DA, Tan SH, Booth GL: The treatment of unrelated disorders in patients with chronic medical diseases. New England Journal of Medicine 338:1516-1520, 1998
21. McKeller J, Humphreys KH, Piette JD: Does depression's effect on diabetes self-care behaviors explain the relationship between depressive symptoms and subsequent diabetes-related physical symptoms? Diabetes Educator 30:485-492, 2004
22. Buchanan RW, Strauss ME, Kirkpatrick B, et al: Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia. Archives of General Psychiatry 51:804-811, 1994
23. Wykes T, Reeder C, Corner J, et al: The effects of neurocognitive remediation on executive processing in patients with schizophrenia. Schizophrenia Bulletin 25:291-307, 1999
24. Aleman A, Hijman R, de Haan EH, et al: Memory impairment in schizophrenia: a meta-analysis. American Journal of Psychiatry 156:1358-1366, 1999
25. Hobart MP, Goldberg R, Bartko JJ, et al: Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia: II. convergent/discriminant validity and diagnostic group comparisons. American Journal of Psychiatry 156:1951-1957, 1999
26. Jeste SD, Patterson TL, Palmer BW, et al: Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophrenia Research 63:49-58, 2003
27. Piette JD, Heisler M: Problems due to medication costs among VA and non-VA patients with chronic illnesses. American Journal of Managed Care 10:861-868, 2004
28. Blow FC, McCarthy JF, Valenstein M, et al: Care in the VHA for Veterans With Psychoses 2000: National Psychosis Registry (2nd Annual Report). Ann Arbor, Mich, VHA Health Services Research and Development, 2001
29. Steiner JF, Koepsell TD, Fihn SD, et al: A general method of compliance assessment using centralized pharmacy records. Medical Care 26:814-823, 1988
30. McCarthy JF, Blow FC: Older patients with serious mental illness: sensitivity to distance barriers for outpatient care. Medical Care 42:1073-1080, 2004
31. Littell RC, Milliken GA, Troup WW, et al: SAS Systems for Mixed Models. Cary, NC, SAS Institute, 1996
32. Piette JD, Heisler M, Krein S, et al: The role of physician trust as a buffer against medication non-adherence due to cost pressures. Archives of Internal Medicine 165:1749-1755, 2005
33. Day JC, Bentall RP, Roberts C, et al: Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Archives of General Psychiatry 62:717-724, 2005
34. Loffler W, Kilian R, Toumi M, et al: Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment. Pharmacopsychiatry 36:105-112, 2003
35. Desai RA, Rosenheck RA: The impact of managed care on cross-system use of mental health services by veterans in Colorado. Psychiatric Services 53:1599-1604, 2002
36. Hoff RA, Rosenheck RA: Cross-system service use among psychiatric patients: data from the Department of Veterans Affairs. Journal of Behavioral Health Services Research 27:98-106, 2000